Patent Applications published on Jul 17, 2025 - page 3

#601
US20250228749A1
Human necessities

Infant Pacifier

#602
US20250228750A1
Human necessities

POWDER FOR USE IN TREATING TOOTH SURFACES

#603
US20250228751A1
Human necessities

APPLICATION OF CALCIUM ALUMINATE IN PRE-MIXED DENTAL FILLING MATERIALS, PRE-MIXED DENTAL FILLING MATERIALS AND THEIR PREPARATION METHODS

#604
US20250228752A1
Human necessities

SOLID CARE AND/OR MAKEUP COMPOSITION

#605
US20250228753A1
Human necessities

METHOD OF PRODUCING SOLID PARTICLE

#606
US20250228754A1
Human necessities

Oral Care Compositions

#607
US20250228755A1
Human necessities

ANHYDROUS COMPOSITION THAT STABILIZES POORLY SOLUBLE INGREDIENTS AND PROVIDES EXCELLENT FEELING OF USE

#608
US20250228756A1
Human necessities

Anhydrous Urea Emulsions with a Retinoid Agent

#609
US20250228757A1
Human necessities

SUNSCREEN COMPOUNDS AND FORMULATIONS

#610
US20250228758A1
Human necessities

Solid Cleansing Compositions

#611
US20250228759A1
Human necessities

ANTI-AGING COSMETIC COMPOSITIONS COMPRISING XANTHOMMATIN

#612
US20250228760A1
Human necessities

HAIR COSMETIC COMPOSITION

#613
US20250228761A1
Human necessities

COMPOSITION COMPRISING A SURFACE-REACTED CALCIUM CARBONATE AND A TANNIN

#614
US20250228762A1
Human necessities

COSMETIC COMPOSITION COMPRISING LUTEIN AND A POLYSACCHARIDE

#615
US20250228763A1
Human necessities

Yeast-Based Masks for Improved Skin, Hair and Scalp Health

#616
US20250228764A1
Human necessities

USE OF PRUNUS LANNESIANA EXTRACT FOR IMPROVING SKIN CONDITION AND BASAL METABOLIC RATE

#617
US20250228765A1
Human necessities

TREATING KNEE JOINT PAIN BY INJECTING RESINIFERATOXIN AT ULTRA LOW DOSES

#618
US20250228766A1
Human necessities

POLYNUCLEOTIDES ENCODING ANTIBODIES WHICH BIND THE EC3 DOMAIN OF CADHERIN-6 (CDH6) AND POSSESS INTERNALIZATION ABILITY

#619
US20250228767A1
Human necessities

COMPOSITIONS AND METHODS FOR DRUG INSTILLATION INTO THE URINARY BLADDER

#620
US20250228768A1
Human necessities

Intestinal-targeted sustained-release of polyphenols and preparation method and application thereof

#621
US20250228769A1
Human necessities

OROMUCOSAL THERAPEUTIC SYSTEM CONTAINING AN ADHESIVE LAYER

#622
US20250228770A1
Human necessities

ALKALINE INTRAORAL FORMULATIONS

#623
US20250228771A1
Human necessities

ALKALINE INTRAORAL PRODUCTS

#624
US20250228772A1
Human necessities

DRUG DELIVERY SYSTEM COMPRISING A REFLUX INHIBITOR FOR THE APPLICATION TO ESOPHAGEAL MUCOUS MEMBRANES

#625
US20250228773A1
Human necessities

PROTECTION OF BIOLOGICAL SPECIES FROM DEGRADATION

#626
US20250228774A1
Human necessities

SYSTEMS AND METHODS FOR ACCELERATED HYDROLYSIS OF POLYSACCHARIDE-BASED HYDROGELS

#627
US20250228775A1
Human necessities

ETHANOLIC RESINIFERATOXIN CONCENTRATE

#628
US20250228776A1
Human necessities

DELIVERY OF AGENTS USING METASTABLE LIPOSOMES

#629
US20250228777A1
Human necessities

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

#630
US20250228778A1
Human necessities

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

#631
US20250228779A1
Human necessities

METHOD AND COMPOSITION FOR TREATING PULMONARY FIBROSIS

#632
US20250228780A1
Human necessities

NOVEL COMPOSITION

#633
US20250228781A1
Human necessities

SOLID COMPOSITION COMPRISING SOLUBILISED BRADYKININ B2-RECEPTOR ANTAGONISTS

#634
US20250228782A1
Human necessities

SOLID EXTENDED-RELEASE COMPOSITION COMPRISING BRADYKININ B2-RECEPTOR ANTAGONISTS

#635
US20250228783A1
Human necessities

PHARMACEUTICAL FORMULATIONS OF A BRUTON'S TYROSINE KINASE INHIBITOR

#636
US20250228784A1
Human necessities

ANTIFIBROTIC COMPOSITION

#637
US20250228785A1
Human necessities

MICROCAPSULE, PREPARATION METHOD THEREFOR, AND USE THEREOF IN PREVENTING AND/OR TREATING DAMAGE TO SALIVARY GLANDS CAUSED BY RADIATION THERAPY

#638
US20250228786A1
Human necessities

METHOD FOR PRODUCING DELIVERY VESICLES

#639
US20250228787A1
Human necessities

BIOLOGICAL MATERIAL FOR DELIVERING SPECIFIC CELL-TARGETED METABOLIC SYSTEM, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#640
US20250228788A1
Human necessities

COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS

#641
US20250228789A1
Human necessities

METHOD FOR PRODUCING ALBUMIN-BOUND TAXANE NANOPARTICLES WITH IMPROVED STABILITY IN MAINTAINING PARTICLE SIZE DISTRIBUTION

#642
US20250228790A1
Human necessities

PARTICLES COMPRISING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND METHODS OF USE THEREOF

#643
US20250228791A1
Human necessities

COMPOSITION FOR USE IN THE TREATMENT OF URINARY OR FAECAL INCONTINENCE

#644
US20250228792A1
Human necessities

WATER-BASED FORMULATION OF DISCREET LIQUID PATCH FOR THE PAIN-FREE TREATMENT OF COLD SORES

#645
US20250228793A1
Human necessities

2,4-Dinitrophenol Formulations and Methods Using Same

#646
US20250228794A1
Human necessities

HOMOVANILLYL ALCOHOL (HVA), HVA ISOMER, METHODS OF MAKING COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND METHODS USING SUCH COMPOUNDS

#647
US20250228795A1
Human necessities

ESTROGENIC COMPOUNDS AND METHODS OF USE

#648
US20250228796A1
Human necessities

SKELETAL MUSCLE ENHANCER

#649
US20250228797A1
Human necessities

SYNERGIC AND STABLE PHARMACEUTICAL COMPOSITION OF AN NSAID AND AN OPIOID ANALGESIC FOR PAIN AND INFLAMMATION

#650
US20250228798A1
Human necessities

INDANE-, INDENE-, AZAINDANE-, AND AZAINDENE-AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS

#651
US20250228799A1
Human necessities

SALT OF A PHARMACEUTICAL COMPOUND

#652
US20250228800A1
Human necessities

Treatment of nasal cavity inflammation and mucus hypersecretion.

#653
US20250228801A1
Human necessities

USE OF Galectin-1 INHIBITOR IN PREPARATION OF DRUG FOR TREATING PULMONARY FIBROSIS

#654
US20250228802A1
Human necessities

EXTENDED RELEASE MIDODRINE HYDROCHLORIDE COMPOSITIONS AND METHODS OF USE

#655
US20250228803A1
Human necessities

NASAL FORMULATIONS OF METOCLOPRAMIDE

#656
US20250228804A1
Human necessities

USES OF SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) COMPOUNDS FOR QUALITY WEIGHT LOSS

#657
US20250228805A1
Human necessities

PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY

#658
US20250228806A1
Human necessities

AMPK ACTIVATOR, MOTOR FUNCTION IMPROVING AGENT, MUSCULAR ENDURANCE IMPROVING AGENT, AND MUSCLE ATROPHY PREVENTING AGENT

#659
US20250228807A1
Human necessities

TRANEXAMIC CLASS ARGININE AND HISTIDINE MIMICS AS THERAPEUTIC AGENTS

#660
US20250228808A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS DISEASES

#661
US20250228809A1
Human necessities

COMPOSITIONS FOR USE

#662
US20250228810A1
Human necessities

COMPOSITIONS FOR USE

#663
US20250228811A1
Human necessities

Triester Compounds And Methods Of Use Thereof

#664
US20250228812A1
Human necessities

FLUORINATED PHENYLAMINO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS

#665
US20250228813A1
Human necessities

METHODS OF ADMINISTRATION FOR HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER

#666
US20250228814A1
Human necessities

COMBINATION THERAPIES FOR THE TREATMENT OF VIRAL INFECTIONS

#667
US20250228815A1
Human necessities

LYOPHILIZED RESINIFERATOXIN

#668
US20250228816A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#669
US20250228817A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#670
US20250228818A1
Human necessities

PHARMACEUTICAL COMBINATION CONTAINING CAPSID PROTEIN INHIBITOR AND REVERSE TRANSCRIPTASE INHIBITOR

#671
US20250228819A1
Human necessities

COMPOSITIONS COMPRISING ATICAPRANT

#672
US20250228820A1
Human necessities

METHODS FOR PREVENTING OR SLOWING THE PROGRESSION OF COGNITIVE DECLINE OR IMPAIRMENT IN SUBJECTS DISPLAYING NORMAL COGNITIVE PERFORMANCE

#673
US20250228821A1
Human necessities

N-DESMETHYL RUBOXISTAURIN AS A KINASE INHIBITOR

#674
US20250228822A1
Human necessities

COMPOSITIONS AND FORMULATIONS FOR USE OF A PK INHIBITOR FOR THE PREVENTION, TREATMENT, AND IMPROVEMENT OF SKIN DISEASES, CONDITIONS, AND DISORDERS

#675
US20250228823A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL

#676
US20250228824A1
Human necessities

COMPOSITIONS AND METHODS FOR INHIBITION OF ITO AS TREATMENT FOR THE J WAVE SYNDROMES AND HYPOTHERMIA

#677
US20250228825A1
Human necessities

COMPOSITIONS OF RAPAMYCIN AND THEIR USE IN THE TREATMENT OF MICROCYSTIC LYMPHATIC MALFORMATION

#678
US20250228826A1
Human necessities

COMBINATION OF A GREMLIN-1 ANTAGONIST WITH AN INHIBITOR OF RAS-RAF-MEK-ERK SIGNALLING

#679
US20250228827A1
Human necessities

METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS

#680
US20250228828A1
Human necessities

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#681
US20250228829A1
Human necessities

FORMULATIONS WITH ENHANCED SN-38 SOLUBILITY AND ORAL ABSORPTION

#682
US20250228830A1
Human necessities

4-AMINOPYRIDINE (4-AP) AND BONE MORPHOGENETIC PROTEIN 2 (BMP-2)

#683
US20250228831A1
Human necessities

METHOD TO PREVENT AND TREAT GLAUCOMA BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

#684
US20250228832A1
Human necessities

METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION

#685
US20250228833A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING AGITATION

#686
US20250228834A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER

#687
US20250228835A1
Human necessities

PYRIDINYLOXYPYRIDINES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

#688
US20250228836A1
Human necessities

BILASTINE COMPOSITION FOR ONCE-DAILY PARENTERAL ADMINISTRATION

#689
US20250228837A1
Human necessities

(2S)-1-[4-(3,4-DICHLOROPHENYL)PIPERIDIN-1-YL]-3-[2-(5-METHYL-1,3,4-OXADIAZOL-2-YL)BENZO[B]FURAN-4-YLOXY] PROPAN-2-OL OR ITS METABOLITE FOR TREATING ANXIETY DISORDERS

#690
US20250228838A1
Human necessities

METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS

#691
US20250228839A1
Human necessities

COMPOSITION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDIN-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE

#692
US20250228840A1
Human necessities

METHODS OF TREATING SJÖGREN-LARSSEN SYNDROME

#693
US20250228841A1
Human necessities

COMPOSITIONS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES

#694
US20250228842A1
Human necessities

USES OF A SOMATOSTATIN MODULATOR FOR THE TREATMENT OF CARCINOID SYNDROME

#695
US20250228843A1
Human necessities

COMPOSITIONS OF CXCR4 INHIBITORS AND METHODS OF PREPARATION AND USE

#696
US20250228844A1
Human necessities

SINGLE NUCLEOTIDE POLYMORPHIC ALLELES OF HUMAN DP-2 GENE FOR DETECTION OF SUSCEPTIBILITY TO HAIR GROWTH INHIBITION BY PGD2

#697
US20250228845A1
Human necessities

COMBINATION DOSAGE FORMS AND ADMINISTRATION THEREOF

#698
US20250228846A1
Human necessities

MORPHINE FORMULATIONS

#699
US20250228847A1
Human necessities

COMBINATION THERAPY FOR TREATING CANCER

#700
US20250228848A1
Human necessities

PROCESS FOR MAKING A KRAS G12C INHIBITOR

#701
US20250228849A1
Human necessities

FORMULATION AND MANUFACTURING PROCESS OF LIQUID FORMULATION OF RILPIVIRINE

#702
US20250228850A1
Human necessities

COMBINATION OF A CXCR7 ANTAGONIST WITH AN S1P1 RECEPTOR MODULATOR

#703
US20250228851A1
Human necessities

ALLOSTERIC INHIBITOR COMPOUNDS FOR OVERCOMING CANCER RESISTANCE

#704
US20250228852A1
Human necessities

CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES

#705
US20250228853A1
Human necessities

Apoptosis Inhibitors

#706
US20250228854A1
Human necessities

HETEROCYCLIC SUBSTITUTED PYRIMIDOPYRAN COMPOUNDS AND THEIR APPLICATIONS

#707
US20250228855A1
Human necessities

PYRAZINAMIDE COMPOUNDS

#708
US20250228856A1
Human necessities

USE OF HEMATOPOIETIC CELL KINASE (HCK) INHIBITOR IN PREPARATION OF DRUG FOR TREATING PULMONARY FIBROSIS

#709
US20250228857A1
Human necessities

BIOSENSOR AND USES THEREOF

#710
US20250228858A1
Human necessities

ANTI-CANCER COMBINATION THERAPY

#711
US20250228859A1
Human necessities

FORMULATIONS OF VILOXAZINE

#712
US20250228860A1
Human necessities

METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)

#713
US20250228861A1
Human necessities

Cancer Treatments Using MTA-Cooperative PRMT5 Inhibitors

#714
US20250228862A1
Human necessities

METHODS OF USING ATR INHIBITORS

#715
US20250228863A1
Human necessities

Methods and Products to Screen and Treat Glioblastoma Multiforme and Other Cancers, Including Breast Cancers, Using A Combination of PI3KINASE Inhibitors With Checkpoint Inhibitors

#716
US20250228864A1
Human necessities

THERAPIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

#717
US20250228865A1
Human necessities

COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME

#718
US20250228866A1
Human necessities

CRYSTALLINE FORM OF (R)-1-(3-(3-(4-AMINOPYRIMIDIN-2-YL)-5-CHLOROPHENYL)MORPHOLINO)PROP-2-EN-1-ONE

#719
US20250228867A1
Human necessities

METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT

#720
US20250228868A1
Human necessities

METHOD OF TREATING AMYOTROPHIC LATERAL SCLEROSIS

#721
US20250228869A1
Human necessities

Benzodiazepine Pyrazolo Carboxamides as N-protein Inhibitors

#722
US20250228870A1
Human necessities

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING BRONCHIECTASIS

#723
US20250228871A1
Human necessities

FULVESTRANT FORMULATIONS

#724
US20250228872A1
Human necessities

PHARMACEUTICAL FORMULATIONS AND SYSTEMS FOR DELIVERY OF AN ANDROGENIC AGENT AND AN AROMATASE INHIBITOR WITH SUSTAINED MULTI-PHASIC RELEASE PROFILES AND METHODS OF USE

#725
US20250228873A1
Human necessities

C25 R AND S ISOMERS OF AMINOSTEROLS AND METHODS OF MAKING AND USING THE SAME

#726
US20250228874A1
Human necessities

CALCITRIOL OR CALCITRIOL ANALOGUES FOR TREATING PERIPERHAL NEUROPATHIC PAIN DISORDERS

#727
US20250228875A1
Human necessities

METHODS OF TREATING, AMELIORATING AND/OR PREVENTING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND HETEROTOPIC OSSIFICATION, AND KITS FOR THE SAME

#728
US20250228876A1
Human necessities

COMPOSITIONS FOR DELIVERY OF CANNABINOIDS

#729
US20250228877A1
Human necessities

MANAGEMENT OF SKIN AILMENTS

#730
US20250228878A1
Human necessities

METHOD FOR THE SYNTHESIS OF EVOC PROBES

#731
US20250228879A1
Human necessities

METHOD AND COMPOSITION FOR CONTROLLING ACNE USING RHAMNOLIPIDS

#732
US20250228880A1
Human necessities

REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS

#733
US20250228881A1
Human necessities

COMPOSITION FOR PREVENTION OR TREATMENT OF MULTIPLE MYELOMA COMPRISING NOVEL TETRACYCLIC TRITERPENE COMPOUND AS ACTIVE INGREDIENT

#734
US20250228882A1
Human necessities

ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS

#735
US20250228883A1
Human necessities

Process to Inhibit or Eliminate Eosinophilic Diseases of the Airway and Related Conditions

#736
US20250228884A1
Human necessities

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

#737
US20250228885A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASES WITH SIRNAS TARGETING GPAM

#738
US20250228886A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF SEPSIS-RELATED DISORDERS

#739
US20250228887A1
Human necessities

OPHTHALMIC COMPOSITION

#740
US20250228888A1
Human necessities

Methods of administering safe colon cleansing compositions

#741
US20250228889A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING HEART CONDITIONS

#742
US20250228890A1
Human necessities

ANTI-CANCER FORMULATION COMPRISING SODIUM PENTABORATE, CURCUMIN AND PIPERINE FOR USE IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA

#743
US20250228891A1
Human necessities

COMBINATIONS CONTAINING OXYLANTHANUM CARBONATE FOR TREATING HYPERPHOSPHATEMIA

#744
US20250228892A1
Human necessities

METHOD FOR MAKING COPPER-SILVER PHOSPHATE OXIDE NANOPARTICLES FROM COPPER OXIDE

#745
US20250228893A1
Human necessities

BROAD SPECTRUM ANTISEPTIC NANO EMULSION BASED ON A COMBINATION OF IONIC LIQUID AND COPPER NANOCLUSTERS

#746
US20250228894A2
Human necessities

TRUNCATED DOMAIN IV EGFR AND USES THEREOF

#747
US20250228895A1
Human necessities

COMPOUNDS TO INHIBIT YTHDF2, T HELPER CELLS LACKING EXPRESSION OF YTHDF2, AND METHODS TO TREAT CANCER

#748
US20250228896A1
Human necessities

MATRIX BOUND NANOVESICLES ENCAPSULATED IN HYDROGELS

#749
US20250228897A1
Human necessities

VAGINAL CARE COMPOSITIONS AND METHODS OF IMPROVING VAGINAL HEALTH

#750
US20250228898A1
Human necessities

METHODS AND COMPOSITIONS FOR NON-MYELOABLATIVE BONE MARROW RECONSTITUTION

#751
US20250228899A1
Human necessities

GENERATING AND UTILIZING ADULT HEPATOCYTE ORGANOIDS

#752
US20250228900A1
Human necessities

NATURAL MATRIX MIXTURE FOR THE TREATMENT OF BONE FRAGILITY

#753
US20250228901A1
Human necessities

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING INFLAMMATORY SKIN DISEASES, COMPRISING CUTIBACTERIUM SP. STRAIN

#754
US20250228902A1
Human necessities

COMBINATION DRUG FOR TREATING MALIGNANT TUMOR

#755
US20250228903A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES

#756
US20250228904A1
Human necessities

SYNBIOTIC COMPOSITIONS FOR METABOLIC MANAGEMENT ESPECIALLY GLUCOSE METABOLISM MANAGEMENT AND MODULATION OF SATIETY HORMONE LEVELS

#757
US20250228905A1
Human necessities

MICROBIAL COMMUNITIES THAT INHIBIT CLOSTRIDIOIDES DIFFICILE AND METHODS OF USING SAME

#758
US20250228906A1
Human necessities

Aqueous liquid extract of Spirulina for the prevention and/or treatment of chemically induced peripheral neuropathy and their symptoms, composition and use thereof

#759
US20250228907A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING METACHROMATIC LEUKODYSTROPHY DISEASE AND RELATED DISORDERS

#760
US20250228908A1
Human necessities

TREATING ORTHOPEDIC INJURY WITH A VECTOR DRIVING EXPRESSION OF ACID CERAMIDASE

#761
US20250228909A1
Human necessities

THERAPEUTIC COMPOSITIONS AND METHODS

#762
US20250228910A1
Human necessities

EXTRACT OF MELASTOMA DODECANDRUM LOUR. FOR TREATING ULCERATIVE COLITIS, PREPARATION METHOD THEREFOR AND USE THEREOF

#763
US20250228911A1
Human necessities

BURDOCK SEED OIL-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME

#764
US20250228912A1
Human necessities

COMPOSITION AND METHODS OF TREATMENT FOR SKIN HEALTH AND SLEEP QUALITY USING SYNERGISTICALLY-ENHANCED SUPPLEMENTATION

#765
US20250228913A1
Human necessities

STABILIZED OMEGA-3 OPHTHALMIC COMPOSITIONS

#766
US20250228914A1
Human necessities

PHARMACOLOGICAL, HEALTH OR DIETARY PREPARATION FOR TREATING HYPOSALIVATION

#767
US20250228915A1
Human necessities

DISTINCT CD8+ T CELL PROGRAMMING IN THE TUMOR MICROENVIRONMENT CONTRIBUTES TO SEX BIAS IN CANCER

#768
US20250228916A1
Human necessities

A METHOD OF TREATING OR PREVENTING SEPSIS

#769
US20250228917A1
Human necessities

METHODS OF TREATING FIBROSIS AND ARRHYTHMIA WITH A NEUREGULIN-1 FUSION PROTEIN

#770
US20250228918A1
Human necessities

METHODS OF CONTROLLING BODY WEIGHT AND/OR ENERGY EXPENDITURE

#771
US20250228919A1
Human necessities

Insulin Derivative

#772
US20250228920A1
Human necessities

LONG-ACTING PARATHYROID HORMONE

#773
US20250228921A1
Human necessities

TREATMENT OF ARGINASE 1 DEFICIENCY

#774
US20250228922A1
Human necessities

METHODS FOR TREATMENT OF DISEASES

#775
US20250228923A1
Human necessities

COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS

#776
US20250228924A1
Human necessities

IDENTIFICATION OF G. PARASUIS IMMUNOGENIC PROTEINS AND SUBUNIT VACCINE COMPRISING SUCH

#777
US20250228925A1
Human necessities

METHODS AND RELATED ASPECTS FOR INCREASING ANTIGENIC INSERTION SITES ON A RECOMBINANT IMMUNE COMPLEX PLATFORM

#778
US20250228926A1
Human necessities

RNA VACCINE LIPID NANOPARTICLES

#779
US20250228927A1
Human necessities

RECOMBINANT FUSION PROTEIN DERIVED FROM HR REGION OF S2 PROTEIN OF SARS-COV-2 AND APPLICATION OF RECOMBINANT FUSION PROTEIN

#780
US20250228928A1
Human necessities

IMMUNE ENHANCEMENT AND INFECTIOUS DISEASE TREATMENT

#781
US20250228929A1
Human necessities

RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN IMMUNIZING AGAINST SARS-COV-2 OMICRON VARIANT

#782
US20250228930A1
Human necessities

SARS-COV-2 RNA VACCINE COMPOSITIONS AND METHODS OF USE

#783
US20250228931A1
Human necessities

ALPHAVIRUS REPLICON ENCODING CHIMERIC SARS-COV-2 RECEPTOR BINDING DOMAINS

#784
US20250228932A1
Human necessities

HUMAN CYTOMEGALOVIRUS VACCINE

#785
US20250228933A1
Human necessities

Human Cytomegalovirus Immunogenic Composition

#786
US20250228934A1
Human necessities

ADENOVIRAL VECTORS ENCODING HEPATITIS B VIRAL ANTIGENS FUSED TO HERPES VIRUS GLYCOPROTEIN D AND METHODS OF USING THE SAME

#787
US20250228935A1
Human necessities

CONSTRUCTION AND APPLICATION OF FUSION PROTEIN VACCINE PLATFORM

#788
US20250228936A1
Human necessities

COMBINATION THERAPY COMPRISING AXL/MER AND PD-1/PD-L1 INHIBITORS

#789
US20250228937A1
Human necessities

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

#790
US20250228938A1
Human necessities

THE COMBINATION OF MACROPHAGE-DIRECTED IMMUNOTHERAPY AND TARGETED AGENTS FOR TREATMENT OF CANCER

#791
US20250228939A1
Human necessities

ENHANCED IMMUNE CELL THERAPY

#792
US20250228940A1
Human necessities

COMPOSITIONS AND METHODS FOR EFFICIENT AND STABLE GENETIC MODIFICATION OF EUKARYOTIC CELLS

#793
US20250228941A1
Human necessities

CELLULAR THERAPY

#794
US20250228942A1
Human necessities

METHODS FOR ACTIVATION AND EXPANSION OF ENGINEERED NATURAL KILLER CELLS AND COMBINATIONS WITH ANTIBODIES

#795
US20250228943A1
Human necessities

CELLS HAVING SOLID TUMOR TARGETING BACKBONE AND USE THEREOF

#796
US20250228944A1
Human necessities

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS

#797
US20250228945A1
Human necessities

NEOANTIGENS AND USES THEREOF

#798
US20250228946A1
Human necessities

ANTI-CD3 ANTIBODY FORMULATIONS

#799
US20250228947A1
Human necessities

METAL-ORGANIC FRAMEWORKS AS SOLID SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS

#800
US20250228948A1
Human necessities

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

#801
US20250228949A1
Human necessities

COLLAGEN MATRICES OF VARYING CHARGE AND CROSS-LINKING DENSITY

#802
US20250228950A1
Human necessities

Prodrugs Activated by Reduction in the Cytosol

#803
US20250228951A1
Human necessities

NOVEL-PEPTIDE-BASED ANTICANCER IMMUNOTHERAPEUTIC AGENT

#804
US20250228952A1
Human necessities

BENZIMIDAZOLE AND BENZIMIDAZOLONE BASED PROTAC COMPOUNDS FOR THE TARGETED DEGRADATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2)

#805
US20250228953A1
Human necessities

INTRACELLULAR TARGETING OF OLIGONUCLEOTIDES

#806
US20250228954A1
Human necessities

Designing Antisense Oligonucleotide Delivery Peptides by Interpretable Machine Learning

#807
US20250228955A1
Human necessities

PLATFORM TECHNOLOGY FOR BISPECIFIC ANTIGENBINDING PROTEINS

#808
US20250228956A1
Human necessities

PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD AND USE THEREOF

#809
US20250228957A1
Human necessities

BIFUNCTIONAL DEGRADERS OF GALACTOSE-DEFICIENT IMMUNOGLOBULINS

#810
US20250228958A1
Human necessities

TSP1 INHIBITOR

#811
US20250228959A1
Human necessities

TRANSFERRIN-BASED LYSOSOME TARGETING DEGRADERS

#812
US20250228960A1
Human necessities

METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY

#813
US20250228961A1
Human necessities

PRACTICAL GLYCAN ENGINEERING METHOD FOR THE PREPARATION OF HOMOGENOUS ANTIBODY CONJUGATES

#814
US20250228962A1
Human necessities

HYDROGEL PRODRUG FOR TREATMENT

#815
US20250228963A1
Human necessities

HYDROGEL PRODRUG FOR TREATMENT

#816
US20250228964A1
Human necessities

PREPARATION OF THERAPEUTIC EXOSOMES USING MEMBRANE PROTEINS

#817
US20250228965A1
Human necessities

NANOPARTICLES COMPRISING AT LEAST ONE METAL SALT AND AT LEAST ONE PEPTIDE

#818
US20250228966A1
Human necessities

LIPID NANOPARTICLE FORMULATIONS AND COMPOSITIONS

#819
US20250228967A1
Human necessities

AAV CAPSID VARIANTS AND USES THEREOF

#820
US20250228968A1
Human necessities

TUMOR-INTRINSIC GALECTIN-3 SUPPRESSES MELANOMA METASTASIS

#821
US20250228969A1
Human necessities

GENE EDITING TO IMPROVE JOINT FUNCTION

#822
US20250228970A1
Human necessities

GENE THERAPY FOR THE TREATMENT OF COGNITIVE DISORDERS

#823
US20250228971A1
Human necessities

DESIGN AND CONSTRUCTION OF EVOLUTIONARY-GUIDED "SELECTION GENE DRIVE" THERAPY

#824
US20250228972A1
Human necessities

METHOD OF PRODUCTION AND USE OF PREPARATION COMPRISING CODON-OPTIMIZED HUMAN COAGULATION FACTOR IX (hFIXco)-TRANSDUCED HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS (tr-HUCMSCs)

#825
US20250228973A1
Human necessities

GENE EDITING METHODS FOR TREATING ALPHA-1 ANTITRYPSIN (AAT) DEFICIENCY

#826
US20250228974A1
Human necessities

MODULATION OF NEURAL PATHWAYS

#827
US20250228975A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING LIPOPROTEIN-RELATED DISEASES

#828
US20250228976A1
Human necessities

AAV CAPSIDS THAT ENABLE CNS-WIDE GENE DELIVERY THROUGH INTERACTIONS WITH THE TRANSFERRIN RECEPTOR

#829
US20250228977A1
Human necessities

Compositions and Methods for Treating Striatonigral Degeneration

#830
US20250228978A1
Human necessities

ENGINEERING SUICIDE GENE APPROACHES TO IMPROVE CHEMOTHERAPEUTIC RESPONSE IN CANCER

#831
US20250228979A1
Human necessities

BIOLOGICAL DEVICES AND COMPOSITIONS FOR INCREASING HAIR GROWTH AND METHODS OF USE THEREOF

#832
US20250228980A1
Human necessities

GENE THERAPY FOR HAPLOINSUFFICIENCY

#833
US20250228981A1
Human necessities

BASE EDITING METHODS AND COMPOSITIONS FOR TREATING TRIPLET REPEAT DISORDERS

#834
US20250228982A1
Human necessities

OXIDATIVE NANOPARTICLES FOR USE IN THE TREATMENT OF DISEASES AND MEDICAL CONDITIONS

#835
US20250228983A1
Human necessities

PROBES FOR CELLULAR SENESCENCE

#836
US20250228984A1
Human necessities

Metallophore-Radionuclide Complex as Nuclear Imaging Contrast Agents

#837
US20250228985A1
Human necessities

COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME

#838
US20250228986A1
Human necessities

Diffusing Alpha-Emitter Radiation Therapy for Lung Cancer

#839
US20250228987A1
Human necessities

SYSTEM AND METHOD FOR WASHING CONTAINERS FOR PHARMACEUTICAL USE

#840
US20250228988A1
Human necessities

FLUID STERILIZATION DEVICE

#841
US20250228989A1
Human necessities

UV DISINFECTION PLATFORM

#842
US20250228990A1
Human necessities

Vehicle Sanitation System

#843
US20250228991A1
Human necessities

A wireless disinfecting apparatus using ozone

#844
US20250228992A1
Human necessities

Enhanced Dispenser Control

#845
US20250228993A1
Human necessities

Enhanced Dispenser Control

#846
US20250228994A1
Human necessities

FRAGRANCE LANYARD

#847
US20250228995A1
Human necessities

BIOACTIVE POLYMERIC DRESSING FOR ACCELERATED WOUND CLOSURE

#848
US20250228996A1
Human necessities

VASCULAR EMBOLIC AGENT, METHOD FOR PREPARING SAME AND USE THEREOF

#849
US20250228997A1
Human necessities

BONE REGENERATIVE AGENT AND METHOD OF USING SAME

#850
US20250228998A1
Human necessities

Anionic Citrate-Based Biomaterials

#851
US20250228999A1
Human necessities

EXTRACELLULAR MATRIX SHEET STRUCTURES

#852
US20250229000A1
Human necessities

ACELLULAR DERMAL TISSUE PREPARED USING SUPERCRITICAL FLUID EXTRACTION, AND USE THEREOF

#853
US20250229001A1
Human necessities

ANCHORED CELL CONSTRUCT CULTURE

#854
US20250229002A1
Human necessities

SYSTEM AND METHODS FOR SOFT-TISSUE AUGMENTATION

#855
US20250229003A1
Human necessities

DISSOLVABLE CALCIUM ALGINATE MICROFIBERS PRODUCED VIA IMMERSED MICROFLUIDIC SPINNING TOWARDS FABRICATION OF EMBEDDED MICROFLUIDIC NETWORKS

#856
US20250229004A1
Human necessities

BIOCOMPATIBLE COMPOSITION, METHOD FOR PREPARING THE SAME, AND METHOD FOR TISSUE ADHESION

#857
US20250229005A1
Human necessities

OXIME-BASED CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS

#858
US20250229006A1
Human necessities

3D PRINTED ARTIFICIAL BILE DUCTS AND MANUFACTURING METHOD THEREOF

#859
US20250229007A1
Human necessities

UNIAXIALLY-ALIGNED NANOFIBER SCAFFOLDS AND METHODS FOR PRODUCING AND USING SAME

#860
US20250229008A1
Human necessities

DELIVERY OF HYDROPHOBIC ACTIVE AGENT PARTICLES

#861
US20250229009A1
Human necessities

MEDICAL WIRE MATERIAL AND GUIDE WIRE

#862
US20250229010A1
Human necessities

PRE-FILLED PLASTIC SYRINGE CONTAINING A VEGF ANTAGONIST

#863
US20250229011A1
Human necessities

THREE-WAY CONNECTING ASSEMBLY AND WEARABLE BREAST PUMP

#864
US20250229012A1
Human necessities

PERITONEAL DIALYSIS SYSTEM AND METHOD HAVING INTRAPERITONEAL PRESSURE SENSING

#865
US20250229013A1
Human necessities

DISPOSABLE CASSETTE CONDITIONING SYSTEM AND METHOD

#866
US20250229014A1
Human necessities

METHOD, DEVICE, EQUIPMENT, AND MEDIUM FOR EVALUATING PATIENT ECMO OPERATION STATUS

#867
US20250229015A1
Human necessities

ENDOVASCULAR IMPLANTS AND DEVICES AND METHODS FOR CREATING A PERCUTANEOUS ARTERIOVENOUS FISTULA

#868
US20250229016A1
Human necessities

APPARATUSES AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPY

#869
US20250229017A1
Human necessities

SYSTEM AND METHODS AND PORTABLE BASE FOR BOWEL IRRIGATION

#870
US20250229018A1
Human necessities

DRUG INFUSION DEVICE WITH INTEGRATED POWER SUPPLY AND ARTIFICIAL PANCREAS

#871
US20250229019A1
Human necessities

PUMP WITH EVACUATED DRIVER

#872
US20250229020A1
Human necessities

SYSTEM AND METHOD FOR MONITORING ACCURACY OF A SYRINGE PUMP

#873
US20250229021A1
Human necessities

Intuitive Total Intravenous Anesthesia Infusion System and Method of Operation

#874
US20250229022A1
Human necessities

INJECTION DEVICE, INJECTION ASSEMBLY AND MONITORING DEVICE

#875
US20250229023A1
Human necessities

CLOSED-LOOP ARTIFICIAL PANCREAS INSULIN INFUSION CONTROL SYSTEM

#876
US20250229024A1
Human necessities

SENSOR MODEL SUPERVISOR FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM

#877
US20250229025A1
Human necessities

MULTI-CARTRIDGE INJECTOR AND METHODS OF MAKING AND USING SAME

#878
US20250229026A1
Human necessities

AUTOMATIC INJECTION DEVICE WITH ROTATION SENSOR

#879
US20250229027A1
Human necessities

CARTRIDGE ASSEMBLY AND FIXING MEMBER

#880
US20250229028A1
Human necessities

DISPENSING DEVICE INCORPORATING DIAPHRAGM

#881
US20250229029A1 ⚡
Human necessities

MEDICAL SYSTEMS, DEVICES, AND RELATED METHODS FOR DELIVERY OF TREATMENT AGENT(S)

#882
US20250229030A1
Human necessities

Universal Dosage Verification System and Method for Medical Syringe

#883
US20250229031A1
Human necessities

AUTOINJECTOR WITH FINGER GRIP

#884
US20250229032A1
Human necessities

INJECTOR WITH REDUCED BREAK LOOSE FORCE

#885
US20250229033A1
Human necessities

INJECTION ENDPOINT MONITORING SYSTEM AND METHOD

#886
US20250229034A1
Human necessities

Automatic feedback mechanism for a medicament delivery device

#887
US20250229035A1
Human necessities

FREEZE-DRY POWDER INJECTOR RESTORING DEVICE

#888
US20250229036A1
Human necessities

Multi-Chamber Syringe with Pressure Valve for Sequential Delivery of Fluids and Methods of Use

#889
US20250229037A1
Human necessities

Medicament Delivery Device

#890
US20250229038A1
Human necessities

METHOD OF PROVIDING A PERSONAL DRUG INJECTION SYSTEM

#891
US20250229039A1
Human necessities

FLUID MANAGEMENT SYSTEMS AND METHODS

#892
US20250229040A1 ⚡
Human necessities

AGENT DELIVERY SYSTEMS AND METHODS OF USING THE SAME

#893
US20250229041A1
Human necessities

Oil Diffuser Device

#894
US20250229042A1
Human necessities

INHALATION DEVICE

#895
US20250229043A1
Human necessities

OXYGEN CONCENTRATOR SYSTEM

#896
US20250229044A1
Human necessities

METHODS AND APPARATUS FOR VENTILATORY TREATMENT OF RESPIRATORY DISORDERS

#897
US20250229045A1
Human necessities

DISPOSABLE ANGLE-ADJUSTABLE VISUAL BRONCHIAL BLOCKER

#898
US20250229046A1
Human necessities

SYSTEMS AND METHODS FOR ASSISTING PATIENT AIRWAY MANAGEMENT

#899
US20250229047A1
Human necessities

PATIENT INTERFACE

#900
US20250229048A1
Human necessities

BIFURCATED CANNULA DEVICE